Cara Cassino
Geen lopende functies
Vermogen: - $ op 30-04-2024
Loopbaan van Cara Cassino
Eerdere bekende functies van Cara Cassino
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CONTRAFECT CORPORATION | Hoofd Techniek/Wetenschap/O&O | 25-09-2015 | 14-08-2022 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 01-12-2014 | 01-09-2015 |
| PFIZER, INC. | Corporate Officer/Principal | 01-01-2008 | 01-01-2013 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 | 01-01-2007 |
| New York University School of Medicine | Corporate Officer/Principal | - | - |
Opleiding van Cara Cassino
| NYU College of Dentistry | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Beurs
- Insiders
- Cara Cassino
- Ervaring